Federal baseline
Federal scheduling remains the starting point for understanding possession, distribution, research, and enforcement risk.
Ibogaine legality in the United States
State-by-State Map
A careful way to read the overlap between federal scheduling, state law, local policy, research activity, and public discussion around ibogaine.
Law changes and proposed policy are not the same thing. This page is an informational overview, not legal or medical advice.
State overlay
States can adopt their own controlled-substance rules, research measures, penalties, and administrative approaches.
Local signals
City or county action can shape local priorities, but it does not displace state or federal law.
Start with the federal rule
One national status, many state contexts
The map is easiest to use when federal law is treated as the base layer rather than as an afterthought.
Ibogaine is listed in Schedule I under the federal Controlled Substances Act. The DEA’s controlled-substance schedule identifies ibogaine within that federal framework. A state may use similar language, adopt a different administrative approach, or pursue a policy proposal, but none of those actions independently removes the federal classification.
That distinction matters because “legal,” “decriminalized,” “authorized,” “researchable,” and “not a local priority” describe different things. The broader federal-status overview is useful for keeping those terms separate before comparing a particular state.
- Federal scheduling and state law can both apply at the same time.
- A proposal, task force, study bill, or public statement is not automatically a change in operative law.
- Research activity is governed through specific approvals and protocols, not a general public-access exception.
The federal framework also explains why treatment claims should be approached carefully. The FDA drug-development process distinguishes investigation from approval, and interest in potential benefits does not itself establish lawful clinical availability in the United States.
Reading a state record
What a state-by-state view can—and cannot—show
A state entry should be read as a current legal snapshot. The relevant questions are whether ibogaine is named in state schedules, whether a statute has changed, whether an agency has issued applicable rules, and whether a measure is enacted rather than merely introduced. These layers can change on different timelines.
State discussion may also be shaped by developments beyond a state’s borders. People comparing possible access routes often encounter information about ibogaine treatment in Mexico, or broader accounts of European ibogaine treatment; neither changes the legal analysis for possession, distribution, or treatment activity in a U.S. state.
For the same reason, a page about ibogaine treatment in Colorado, an account of ibogaine treatment in Texas, or a discussion of ibogaine treatment in Utah should not be read as proof of a statewide lawful treatment pathway. Location-specific information needs to be checked against the governing law and any applicable federal rule.
“A map is a starting point for verification—not a substitute for the statute, regulation, or official agency record that controls.”
Policy signals
Separate current law from the conversation around it
Plant source is not a legal shortcut
Questions about ibogaine-containing plants and questions about ibogaine itself can involve separate factual and legal issues. A botanical source, a compound, an extract, and a finished product are not automatically treated the same way in every legal setting.
The term ibogaine street name can also create confusion in informal discussions. Clear legal analysis begins by identifying the exact substance, conduct, and jurisdiction at issue rather than relying on informal labels.
Interest is not authorization
Public interest in ibogaine therapy benefits or in ibogaine for alcohol addiction does not determine legal status. Health-related claims should be evaluated separately from the question of whether a substance or service is lawful in a particular jurisdiction.
The National Center for Complementary and Integrative Health describes why evidence, safety, and regulation need to be assessed together when considering complementary health approaches; its federal health-information guidance on psychoactive botanical preparations illustrates the importance of not treating public interest as a regulatory finding.
A verification sequence
Use primary sources before relying on summaries
State legal status is a moving target, especially when bills, ballot efforts, and local resolutions are part of the public conversation.
Begin with current statutory text and the state’s controlled-substance schedule. Then look for effective dates, implementing regulations, court decisions where relevant, and whether the item being discussed is an enacted law, a pending bill, or a local measure. The official Congress.gov legislative record is one example of why bill status and enacted text must be distinguished.
News summaries can help identify developments, but the underlying official material should control the conclusion. Readers following ongoing developments may compare that context with current ibogaine developments, while still treating statutes and agency records as the final checkpoint.
People assessing non-U.S. options may also see information about an ibogaine retreat in Mexico. That information may be relevant to travel questions, but it does not answer the separate question of U.S. federal or state law. For an organized overview of legal categories and uncertainty, return to the main legal-status guide and compare it with the site’s explanation of how the resource organizes legal information.
Common questions
Reading the map with appropriate caution
Does a state policy change make ibogaine legal under federal law?
No. State law and federal law can operate at the same time. A state measure may change state-level consequences, research policy, or priorities, but it does not by itself change ibogaine’s federal controlled-substance status.
Can a local policy create a legal treatment pathway?
A local policy can affect local enforcement priorities, but it does not replace state law or federal law. It should not be treated as authorization to provide or receive medical treatment.
Where should a reader verify a current state rule?
Start with the state legislature, code publisher, regulatory agency, or official ballot materials, then distinguish enacted text from a proposal, agency guidance, or local resolution.
Keep the categories clear
A careful legal reading leaves room for uncertainty.
Federal scheduling, state statutes, research activity, local measures, and public discussion each answer different questions. Confirm the jurisdiction, the date, and the original source before treating any summary as a practical legal conclusion.